Peter Westley
CIK 1663979 · View on SEC EDGAR ↗
First SEC filing: Aug. 1, 2023 · Latest: Aug. 1, 2023
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 28, 2023 | CURI | D | 221,904 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-19) |
| July 28, 2023 | CURI | D | 50,000 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-19) |
| July 28, 2023 | CURI | A | 134,813 | — | — | 134,813 Direct | — | Acquired | (price as of 2026-08-19) |
| July 28, 2023 | CURI | A | 44,249 | — | — | 44,249 Direct | — | Acquired | (price as of 2026-08-19) |
| June 1, 2023 | CURI | F | 24,857 | $0.90 | $22,371 | 47,211 Direct | -34.49% | Disposed | 224.4% (price as of 2026-08-19) |
| May 24, 2023 | CURI | M | 72,068 | — | — | 216,203 Direct | -25.00% | Disposed | (price as of 2026-08-19) |
| May 24, 2023 | CURI | M | 72,068 | — | — | 72,068 Direct | — | Acquired | (price as of 2026-08-19) |
| May 21, 2022 | CURI | A | 288,271 | — | — | 288,271 Direct | — | Acquired | (price as of 2026-08-19) |
| May 21, 2022 | CURI | A | 221,904 | — | — | 221,904 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 28, 2023 | CURI | Stock Options (right to buy) | Common Stock (221,904) | $1.62 | — | 221,904 | Disposed |
| July 28, 2023 | CURI | Stock Options (right to buy) | Common Stock (50,000) | $2.32 | — | 50,000 | Disposed |
| July 28, 2023 | CURI | Restricted Stock Units | Common Stock (134,813) | — | — | 134,813 | Acquired |
| July 28, 2023 | CURI | Restricted Stock Units | Common Stock (44,249) | — | — | 44,249 | Acquired |
| May 24, 2023 | CURI | Restricted Stock Units | Common Stock (72,068) | — | — | 72,068 | Disposed |
| May 21, 2022 | CURI | Restricted Stock Units | Common Stock (288,271) | — | — | 288,271 | Acquired |
| May 21, 2022 | CURI | Stock Options (right to buy) | Common Stock (221,904) | $1.62 | May 21, 2032 | 221,904 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CURI
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $129,167 | — | — | — | — | — | $39,494 | $168,661 |
| 2023 | $310,000 | — | $182,643 | — | $90,000 | — | $84,170 | $666,813 |
| 2022 | $188,368 | — | $466,999 | $304,999 | $90,000 | — | $21,879 | $1,072,245 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.